Hep C Testing Recommendations Developed for Perinatally Exposed Infants

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 2, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Nov. 2, 2023 -- Recommendations have been developed for hepatitis C virus (HCV) testing among perinatally exposed infants. The recommendations and report are published in the Nov. 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Noting that about 6 to 7 percent of perinatally exposed infants and children will acquire HCV infection and that many perinatally infected children are not tested or linked to care, Lakshmi Panagiotakopoulos, M.D., from the CDC in Atlanta, and colleagues introduced four new recommendations for HCV screening of perinatally exposed infants and children.

The report issued four recommendations: All perinatally exposed infants should undergo HCV testing at age 2 to 6 months with a nucleic acid test (NAT) for HCV RNA detection; all infants and children with detectable HCV RNA should consult with health care providers with expertise in pediatric hepatitis C management; no further follow-up or testing is recommended for perinatally exposed infants and children with an undetectable HCV RNA result at or after age 2 months, unless clinically warranted; and NAT is recommended for perinatally exposed infants and children aged 7 to 17 months who have not been tested previously. For perinatally exposed children aged 18 months and older who have not been tested previously, hepatitis C virus antibody testing is recommended, followed by NAT for HCV RNA.

"Using a testing strategy of highly sensitive and specific NATs for RNA detection among infants and children perinatally exposed to HCV increases the identification of children with HCV infection in whom substantial morbidity and mortality might develop," the authors write.

Abstract/Full Text

Source: HealthDay

Posted : 2023-11-03 08:30

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords